• Viperin Targets nsp8 to Block Coronavirus Replication

  2026-08-07

  The reference study identifies a ddhCTP-independent antiviral mechanism in which viperin binds coronavirus nsp8 and disrupts replication-transcription complex assembly and RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the authors map the interaction to viperin residues 43–184 and nsp8 K82, providing a mechanistic framework for evaluating conserved anti-coronavirus targets.

• Tubastatin A: HDAC6 Inhibitor Workflows for Myocardial Prote

  2026-08-07

  Tubastatin A stands apart as a highly selective HDAC6 inhibitor, unlocking new experimental avenues in myocardial injury, neuroprotection, and inflammation research. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights grounded in the latest translational breakthroughs.

• Nuclear cGAS Suppresses L1 Retrotransposition via CHK2-TRIM4

  2026-08-06

  This study uncovers a novel genome-protective function for nuclear cGAS in human cells, revealing that it restricts LINE-1 retrotransposition through a CHK2-dependent TRIM41-ORF2p degradation pathway. The findings clarify a key posttranslational regulatory mechanism and have implications for aging, genome stability, and cancer research.

• Tumor-Targeted PAD4 Inhibitors Block NET-Mediated Metastasis

  2026-08-06

  This study introduces phenylboronic acid (PBA)-modified PAD4 inhibitors that selectively target tumor cells and neutrophils, blocking the PAD4-H3cit-NETs pathway linked to tumor growth and metastasis. The findings highlight a new approach to cancer therapy by combining molecular targeting with immune microenvironment modulation.

• Dihydroartemisinin: Precision Applications and mTOR Pathway

  2026-08-05

  Explore the advanced scientific landscape of Dihydroartemisinin, a potent Artemisia plant extract, focusing on its precision use as an mTOR signaling pathway inhibitor and in antimalarial research. This article uniquely bridges molecular mechanisms with protocol optimization, offering deeper guidance for translational research teams.

• Flexible Phage Nanofibers Enhance Capture of Rare Circulatin

  2026-08-05

  This study introduces a novel approach using flexible M13 phage nanofibers, engineered with cell-specific aptamers and tethered to magnetic beads, to selectively isolate and subtype rare circulating tumor cells (CTCs) from whole blood. The work demonstrates substantial improvements in both target-cell capture efficiency and anti-fouling properties, providing a significant advance for liquid biopsy and cancer diagnostics.

• Polymeric Nanoplatforms Enhance cGAS-STING in Macrophages fo

  2026-08-04

  The referenced study introduces a mannose-modified, pH-responsive polymeric nanoplatform co-delivering R848 and 2'3'-cGAMP to reprogram tumor-associated macrophages and enhance antitumor responses. This approach downregulates SIRPα in macrophages via STING activation, potentiates phagocytosis, and synergizes with immune checkpoint blockade, offering a multifaceted strategy for cancer immunotherapy.

• Strategic Antioxidant Screening: DPPH and Translational Inno

  2026-08-04

  This thought-leadership article explores how DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical underpins translational antioxidant research, integrating mechanistic insights with actionable guidance. Drawing on comparative metabolomics of Taihangia rupestris, it positions APExBIO’s DPPH as an essential tool for high-throughput screening and sustainable drug discovery, and provides strategic recommendations for protocol optimization and future-ready translational workflows.

• FH1 Small Molecule: Unlocking Advanced Hepatocyte Maturation

  2026-08-03

  Explore how FH1, a potent small molecule, revolutionizes cultured hepatocyte function enhancement and iPS cell differentiation. This in-depth analysis reveals practical protocols, mechanistic insight, and new applications, distinguishing FH1 from conventional approaches.

• Lysoptosis: Cathepsin-Driven Cell Death and Serpin Modulatio

  2026-08-03

  The referenced study establishes lysoptosis as a distinct, evolutionarily conserved cell death pathway driven by lysosomal membrane permeabilization (LMP) and cathepsin release, particularly in the absence of intracellular serpins. These findings clarify the molecular underpinnings of lysosome-dependent cell death and offer mechanistic insight relevant for researchers studying regulated cell death and cysteine protease inhibition.

• G-Quadruplexes Modulate TDP-43 Aggregation and Toxicity in A

  2026-08-02

  Oldani et al. (2025) demonstrate that RNA G-quadruplexes directly influence the condensation, distribution, and cytotoxicity of the neurodegeneration-linked protein TDP-43 in vitro and in multiple cell types. These findings underscore the therapeutic potential of targeting RNA G-quadruplex structures to modulate protein aggregation in diseases such as ALS.

• AO/PI Double Staining: Mechanistic Insight & Translational I

  2026-08-01

  This thought-leadership article offers translational researchers a rigorous, mechanistic, and evidence-driven exploration of dual-dye cell viability assays. It weaves the biological rationale of Acridine Orange/Propidium Iodide staining with latest advances in rare cell capture for cancer subtyping, drawing actionable insights from APExBIO’s AO/PI Double Staining Kit. The discussion navigates experimental validation, competitive landscape, and translational relevance, culminating in a visionary outlook that addresses current limitations and future directions. Distinct from standard product pages, this article bridges molecular detail and strategic guidance, referencing both foundational and cutting-edge literature.

• Acetylspiramycin (Spiramycin B): Mechanisms and Assay Innova

  2026-07-31

  Explore how Acetylspiramycin (Spiramycin B) advances antimicrobial resistance research through unique ribosomal inhibition mechanisms and immune modulation. Discover expert protocol guidance and critical insights from the latest clinical findings.

• Cyclic Pifithrin-α Hydrobromide: Precision p53 Inhibition fo

  2026-07-31

  Explore the advanced utility of Cyclic Pifithrin-α hydrobromide as a p53 inhibitor in dissecting neuroinflammatory pathways and apoptosis inhibition in cancer research. This article provides a scientifically rigorous guide to leveraging this compound for innovative mechanistic studies beyond conventional workflows.

• Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X

  2026-07-30

  The Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) is formulated to prevent protein degradation and dephosphorylation during extraction from diverse biological samples. It is particularly suited for workflows where metal chelation by EDTA is undesirable, such as studies involving metalloproteins or downstream metal-dependent assays. This reagent is not designed for applications where EDTA-mediated chelation is required for maximal inhibition.

15228 records 1/1016 page Next 12345 下5页 Last page